Tao Capital

Asia, Beijing, China, Beijing

Description

Tao Capital is an investment firm.

Investor Profile

Tao Capital has made 7 investments, with 1 in the past 12 months and 14% as lead.

Stage Focus

Series C (43%)
Series B (29%)
Seed (14%)
Series A (14%)

Country Focus

China (57%)
United States (43%)

Industry Focus

Health Care
Biopharma
Biotechnology
Medical
Pharmaceutical
Energy
Energy Management
Oil And Gas
Oncology
Therapeutics

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tao Capital frequently co-invest with?

Huatai Securities

Asia, Jiangsu, China, Nanjing

Co-Investments: 1

Boquan Capital

Asia, Shanghai, China, Hongkou

Co-Investments: 1

CITIC Securities

Asia, Guangdong, China, Shenzhen

Co-Investments: 1

DT Capital Partners

Asia, Shanghai, China, Shanghai

Co-Investments: 1

Yanchuang Capital

Asia, Beijing, China, Beijing

Co-Investments: 2

Qiming Venture Partners

Asia, Shanghai, China, Shanghai

Co-Investments: 3

Decheng Capital

North America, California, United States, Menlo Park

Co-Investments: 1

Dyee Capital

Asia, Fujian, China, Xiamen

Co-Investments: 1

What are some of recent deals done by Tao Capital?

Challenge IM

Daxing, Beijing, China

Challenge IM focuses on the development and application of membrane filtration process products in the biopharmaceutical field.

BiopharmaHealth CareMedical

SeedOct 10, 2024

Gaugene

Beijing, Beijing, China

Gaugene provides hematology testing instruments, reagents, and services for IVD users.

BiotechnologyHealth Diagnostics

Series BJul 15, 2022

Amount Raised: $14,798,591

Crusoe Energy Systems

Denver, Colorado, United States

Crusoe Energy Systems provides solutions for the energy industry helping them to reduce routine flaring of natural gas.

EnergyEnergy ManagementOil and Gas

Series CApr 21, 2022

Amount Raised: $350,000,000

Tingsheng Technology

Nanjing, Jiangsu, China

Tingsheng Technology develops intra cardiac ultrasound ICE products.

Health CareMedical Device

Series AMar 3, 2022

Amount Raised: $15,822,034

Immune-Onc Therapeutics

Palo Alto, California, United States

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

BiopharmaBiotechnologyHealth CareMedicalOncologyTherapeutics

Series BMar 30, 2021

Amount Raised: $73,000,000

Ark Biosciences

Shanghai, Shanghai, China

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development

BiopharmaBiotechnologyHealth CarePharmaceutical

Series CJan 22, 2021

Amount Raised: $86,000

PAX Labs

San Francisco, California, United States

PAX Labs designs, develops, and sells premium cannabis vaporization technologies and devices.

CannabisConsumer ElectronicsManufacturingProduct Design

Series CJun 10, 2015

Amount Raised: $46,700,000

Tao Capital

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Tao Capital frequently co-invest with?

What are some of recent deals done by Tao Capital?

Ready to Raise Capital?

Pages

Free tools